Companies

the cultivated-meat division of Eat Just that secured FDA safety clearance in March 2023 and the first USDA label approval in June 2023, and cut its production cost by 90 percent between 2018 and 2022 while deploying 250,000-litre bioreactor designs.

a Norwegian biotech running a patented continuous enzymatic hydrolysis of fresh (never-frozen) salmon heads and bones at the processing plant, yielding three zero-waste products — purified fish oil OmeGo, soluble protein hydrolysate ProGo and joint calcium powder CalGo.

HTL Biotechnology in Brittany (a more than 64,000 m² site) is a global leader in pharmaceutical-grade biopolymers, running fermentation through extraction and purification on a solvent-free route and inaugurating a new sterile hyaluronic-acid production line on 6 June 2025.

a 2019 University of Oxford spinout producing cultivated beef on a three-tonne-per-year pilot bioreactor and partnering with Finland's Synbio Powerlabs to scale toward 10,000-litre and 27,000-litre fermenters for first commercial sales.

the world's pioneering WBE R&D centre, which first detected SARS-CoV-2 in Amsterdam Schiphol airport sewage; its long-term study quantified the virus in 98.6% (273/277) of samples and resolved variants in 91.0% (161/177) of sequenced samples between February 2020 and September 2022.

the Delft-based developer whose opti-ox stem-cell technology — recognised by TIME as a best invention of 2024 — compresses the cell-cultivation cycle to four days and reached 500-litre pilot bioreactors, targeting profitable unit economics at 10,000-litre scale.

the FDA approved Medtronic's Evolut FX+ TAVR for an expanded Redo-TAVR indication in August 2025, and Medtronic earned the CE Mark for redo-TAVI procedures, extending valve-in-valve therapy for high-risk patients.

the world's first industrial-scale bee-free honey brand, with B2B supply to vegan confectionery and cosmetics makers and retail roll-outs in Europe with Aldi.

MicroPort and Lepu are among China's top cardiovascular-device companies, leading the domestic drug-eluting stent and pacemaker rankings built on the VBP winners' list.

BD Biosciences runs the Rhapsody multi-omics platform, and Mission Bio's Tapestri reads somatic DNA mutations and proteins per cell, used to monitor leukaemia therapy.

the Beijing start-up NeuraMatrix (宁矩科技) builds its own low-power, high-channel BCI ASIC chips for neural signal digitization and stimulation, and produces wireless research BCI systems for primates while preparing clinical-grade platforms.

peptide bioactivity research — pilot lines and clinical peptide trials for diabetes.

Nuritas PeptiStrong cleared the FDA GRAS process, removing restrictions on its use in foods, beverages and supplements across the United States.

spun out of MSD/Merck in 2021, Organon is the largest dedicated women's-health company, reporting $6.2 billion in full-year 2025 revenue and $1.91 billion adjusted EBITDA (30.7% margin), with the postpartum-haemorrhage Jada System and the Nexplanon contraceptive implant.

Parexel brings 40 years and 22,000+ staff to early-access and oncology development (560+ oncology studies, 104,000 patients, 26,000 sites, 50+ countries over five years), while Premier Research's Virtual Research Group supports late-phase and named-patient programs with remote and hybrid trial delivery.

the Benelux-focused recycling specialist handled 9.7 million tonnes of waste in FY25, recycling 6.4 million tonnes at a 66.1% rate, and is investing in a new Amsterdam refrigeration plant to keep organic-waste-to-green-gas throughput at full capacity through hot summers.

Peptan — high-bioavailability collagen peptides for joint and skin.

a leading European producer of pure collagen from wild Arctic cod skin caught in the clean waters of the Norwegian and Barents seas, MSC-certified and sold in more than 40 countries.

a Singapore pioneer of cell-cultivated crustaceans — shrimp, lobster and crab — that is merging with Umami Bioworks to pool cell-line and scale-up assets for the Asia-Pacific market.

Siemens Healthineers reported €23.4 billion in FY25 revenue (+5% year on year), led by €12.1 billion in imaging, anchoring a German medtech belt alongside B. Braun and Fresenius.

the German single-cell company supplies its own capture platform and reagents, giving Europe a non-10x instrument route to single-cell services.

Stryker's Mako SmartRobotics now covers knee, hip and (in full market release from 2026) shoulder arthroplasty, with the handheld Mako RPS entering limited release in February 2026; Stryker reported $11.2 billion in 2025 orthopedic sales.

the Stentrode is implanted within the motor cortex via the jugular vein in an endovascular procedure with no craniotomy; Synchron reported positive results from the US COMMAND early-feasibility study and is positioning a 2026 pivotal trial targeting the first FDA commercial approval in motor BCI.

pairs early-access pathway design for CNS and oncology assets with its Kinetic AI commercial-intelligence engine, whose KAI Conversations conversation-intelligence module is already used by 10 of the top 20 global pharmaceutical companies.

a Californian pioneer that holds FDA and USDA clearance for a whole-textured cultivated-chicken fillet and runs 2,000-litre production batches at its EPIC engineering centre, funded by a $400M Series C round in 2022.

the global waste and water operator runs enclosed aerobic composting and anaerobic-digestion lines; its new Fuentes de Ebro (Zaragoza) plant processes 27,000 tonnes of organic waste per year across two treatment streams (sewage sludge and municipal organic waste) alongside forestry/residue biomass fuel.

the Alphabet life-sciences subsidiary partners with Stanford and Emory universities to run a settled-solids network spanning 147 plants across 40 states and >37 million people, reporting SARS-CoV-2 N-gene RNA in ~94% of February 2026 samples (median 31,869 copies/gram).

North America's largest recycler and environmental-solutions provider runs the CORe process (pre-processing organic waste into high-BTU slurry for digesters) and in April 2026 celebrated the grand opening of new, modernised high-tech recycling and RNG facilities across the US.

the San Francisco company whose cell-cultivated coho salmon received an FDA "no questions" letter in 2024, making it the first cultivated seafood cleared for US sale and the third cultivated protein after Upside Foods and Good Meat, with the product debuted on US restaurant menus.

the non-profit Wyss Center develops the fully-implanted Wyss Able ECoG system for home (not only lab) use in locked-in syndrome, and a 5-year follow-up of a fully implanted BCI in a spinal-cord-injury patient was published in 2025; its academic partners have demonstrated a streaming brain-to-voice neuroprosthesis.

the Yellow Sea Fisheries Research Institute is China's lead state centre for marine-by-product biotech, holding dozens of patents on combined collagen, hyaluronic-acid and sulfated-polysaccharide recovery from fish scales and cartilage.

research groups specialize in the enzymatic kinetics of bee amylases and invertases and on scaling protein expression in methylotrophic yeast.

the Nanjing Agricultural University incubated enterprise that produced China's first cell-cultured meat in 2019 and, in 2025, built the country's largest pilot plant — completing the world's first 2,000-litre bioreactor scaled trial of cultivated pork at a 50-tonne-per-year capacity.

Ritebite Max Protein — protein and peptide snacking and beverage portfolio.

founded by Lisa Dyson on NASA 1960s closed-loop food research, Air Protein grows oxyhydrogen microbes into a meat-mimicking protein and runs a pilot facility in California.

AMSilk produces 100% protein-based recombinant spider-silk yarns that reached consumer garments in 2026, and supplies lightweight biotech materials for aerospace and premium apparel.

a US-led network (including the Kate Adamala lab at the University of Minnesota) coordinates bottom-up artificial-cell research and open standards for vesicle bioengineering.

Calysseo — the Calysta and Adisseo joint venture — commissioned a commercial-scale gas-protein plant in Chongqing supplying FeedKind to Asia's large aquaculture sector and displacing imported fishmeal.

Calysta pioneered methanotroph gas fermentation, producing the single-cell protein FeedKind from Methylococcus capsulatus with high nutritional value for aquaculture and pet diets.

Cathay engineers microbes to produce long-chain dibasic acids, a class of biobased monomers for polymers and lubricants, and is a flagship of China's industrial-synbio push.

COFCO runs carbon-neutral grain supply chains and MARA clears biological and regenerative inputs, tying the practices to national carbon-neutrality goals.

Metabolic Health Solution — Microbiome-based glycaemic prediction for chronic disease.

Finland's Enifer is reviving the historic Pekilo mycoprotein process, fermenting Paecilomyces variotii on pulp- and agro-industrial side-streams; its Finnish plant of about 3,000 tonnes per year is slated to begin supply in 2026, with the product cleared by EFSA for fish and pet feed.

ePE platforms — Enhanced prime editing in crops and cells.

the J. Craig Venter Institute remains the world centre for minimal-genome research, having built the JCVI-syn1.0 to JCVI-syn3.5 series and continuing to assign function to the "dark genes" still uncharacterised in the minimal genome.

Levels Health operates a CGM-as-a-service platform built on FDA-cleared Dexcom and Abbott Libre sensors with a proprietary analytics layer, selling metabolic optimisation to non-diabetic users.

Synthetic chloroplasts, vesicle chassis — Bottom-up cell assembly with photosynthetic energy generation.

3D-printed gummies — Up to 7 actives layered in one sugar-free gummy by 3D printing.

Solar Foods operates the world's first commercial-scale gas-fermentation food-protein plant, Factory 01 near Helsinki, producing up to 160 tonnes of Solein a year since April 2024 from a 20,000-litre bioreactor.

PROSEI — Multi-substrate biomethane gas fermentation.

Twist manufactures synthetic DNA on a silicon platform and in 2026 launched Complex Genes (early access) for challenging repeat-rich sequences, feeding every downstream build.

Denmark's Unibio developed a continuous U-Loop methane-fermentation technology for its Uniprotein product and licenses it internationally; with the Saudi Industrial Investment Group it is building a plant of 50,000 tonnes per year, with expansion planned toward 300,000 tonnes per year.

Swiss and neighbouring institutes pioneer AAV-based delivery of prime editors for in-vivo correction of inherited metabolic liver defects.

Viome runs high-throughput RNA sequencing of the microbiome and holds an FDA Breakthrough Device designation for its saliva-based oral and throat cancer detection test, anchoring its clinical credibility.

ZOE, co-founded by a King's College London genetic epidemiologist, sells a test-kit-plus-subscription that combines stool shotgun metagenomics, a 14-day Abbott Libre Sense CGM and standardised meals into an app of personal food scores, scaling from the UK into the US.

Plant-derived coatings — Lipid/cutin-based barrier.

Provides sample and biological-material storage and automated cryogenic systems (e.g. CryoArc) spanning discovery to clinical trials.

Large-scale soil treatment — Integrated site remediation.